Bristol-Myers investors are paid a 2.45% dividend. Credit Suisse puts a $68 price target on the stock. The consensus target is much lower at $63.41. Shares closed trading Thursday at $60.23. Another top company in the health care sector that makes the …
24/7 Wall ST · 2/6/2015
Instead of worrying about whether or not this relentless pace of stock appreciation can continue ... Valeant is also seeing strong growth in China, the Middle East, and Russia. Bristol-Myers Squibb Company (BMY) recently hit a 14-year high.
Investopedia · 3/17/2015
Bristol-Myers' stock was up marginally at $67.47 on the New York Stock Exchange. (Reporting by Anjali Rao Koppala in Bengaluru; Editing by Sriraj Kalluvila)
Reuters · 6/25/2015
One or more coauthors reports research agreements, grants, personal fees, and/or stock ownership in one or more of the following: National Institutes of Health, Gilead Sciences, Merck, Pfizer, Johnson & Johnson, and …
Medscape News · 13 hours ago
30, 2015. Bristol-Myers' stock was little changed on the New York Stock Exchange after the bell on Wednesday, (Reporting by Samantha Kareen Nair and Natalie Grover in Bengaluru; Editing by Anil D'Silva and Christian Plumb)
Yahoo News · 10/28/2015
This call bias is nothing new for BMY speculators. The stock's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio has jumped from 1.80 to 4.40 during the past …
Schaeffer's Investment Research · 9/18/2015
Wiernik also served in leadership roles for global outsourcing at Teva Pharmaceuticals, Bristol Myers Squibb (BMS ... 300183711.html SOURCE Profil Institute for Clinical Research, Inc. Stock Market XML and JSON Data API provided by FinancialContent ...
Financial Content · 18 hours ago
Profil Institute
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among …
YCharts · 12/31/2014
BMY) today declared a quarterly dividend of thirty-seven cents ($0.37) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 2, 2015, to stockholders of record at the close of business on ...
Business Wire · 9/17/2015
Bristol-Myers shares rose 3.5 percent to $64.34 at the close. Volume surged in bullish options that don’t pay out unless the stock rises at least 8 percent by mid-October from Thursday’s close. Trading in calls exercisable at $67.50 reached 8,123 ...
Bloomberg · ByCrayton Harrison · 9/18/2015
NEW YORK – Shares of UniQure NV soared 44% in premarket trade Monday, after the gene therapy company announced a collaboration deal with Bristol-Myers Squibb , which includes Bristol-Myers acquiring an initial equity stake of 4.9% in UniQure.
Fox Business · 4/6/2015

Bristol-Myers Squibb

Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-M…
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."
Data from: Wikipedia · Freebase